Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010003 PGE2 cPLA2i 1.0 BCD110605C28 0.137 pmol/ml medium
LMFA03010003 PGE2 cPLA2i 1.0 BCD110605C30 0.129 pmol/ml medium
LMFA03010003 PGE2 cPLA2i 1.0 BCD110605C29 0.149 pmol/ml medium
LMFA03010003 PGE2 cPLA2i 20.0 BCD110605C64 0.157 pmol/ml medium
LMFA03010003 PGE2 cPLA2i 20.0 BCD110605C66 0.142 pmol/ml medium
LMFA03010003 PGE2 cPLA2i 20.0 BCD110605C65 0.153 pmol/ml medium
LMFA03010003 PGE2 PLDi 1.0 BCD110605C16 0.117 pmol/ml medium
LMFA03010003 PGE2 PLDi 1.0 BCD110605C17 0.109 pmol/ml medium
LMFA03010003 PGE2 PLDi 1.0 BCD110605C18 0.164 pmol/ml medium
LMFA03010003 PGE2 PLDi 20.0 BCD110605C54 0.195 pmol/ml medium
LMFA03010003 PGE2 PLDi 20.0 BCD110605C52 0.196 pmol/ml medium
LMFA03010003 PGE2 PLDi 20.0 BCD110605C53 0.229 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 1.0 BCD110605C32 0.126 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 1.0 BCD110605C31 0.145 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 1.0 BCD110605C33 0.11 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 20.0 BCD110605C68 0.32 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 20.0 BCD110605C69 0.309 pmol/ml medium
LMFA03010003 PGE2 KDO+cPLA2i 20.0 BCD110605C67 0.321 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 1.0 BCD110605C19 0.147 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 1.0 BCD110605C20 0.155 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 1.0 BCD110605C21 0.172 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 20.0 BCD110605C56 0.535 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 20.0 BCD110605C57 0.658 pmol/ml medium
LMFA03010003 PGE2 KDO+PLDi 20.0 BCD110605C55 0.599 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.172 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.134 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.142 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.363 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.36 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.349 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 1.0 BCD110605C25 0.163 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 1.0 BCD110605C27 0.163 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 1.0 BCD110605C26 0.15 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 20.0 BCD110605C61 0.975 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 20.0 BCD110605C62 1.01 pmol/ml medium
LMFA03010003 PGE2 KDO+ATP+PLDi 20.0 BCD110605C63 0.904 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 1.0 BCD110605C15 0.138 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 1.0 BCD110605C14 0.166 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 1.0 BCD110605C13 0.144 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 20.0 BCD110605C49 1.04 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 20.0 BCD110605C50 0.953 pmol/ml medium
LMFA03010003 PGE2 KDO + ATP 20.0 BCD110605C51 1.07 pmol/ml medium
LMFA03010003 PGE2 KDO 1.0 BCD110605C08 0.174 pmol/ml medium
LMFA03010003 PGE2 KDO 1.0 BCD110605C07 0.114 pmol/ml medium
LMFA03010003 PGE2 KDO 1.0 BCD110605C09 0.118 pmol/ml medium
LMFA03010003 PGE2 KDO 20.0 BCD110605C45 0.594 pmol/ml medium
LMFA03010003 PGE2 KDO 20.0 BCD110605C44 0.643 pmol/ml medium
LMFA03010003 PGE2 KDO 20.0 BCD110605C43 0.547 pmol/ml medium
LMFA03010003 PGE2 C 0.0 BCD110605C03 0.177 pmol/ml medium
LMFA03010003 PGE2 C 0.0 BCD110605C01 0.145 pmol/ml medium